CoreFirst Bank & Trust Takes Position in Cardinal Health, Inc. (NYSE:CAH)

CoreFirst Bank & Trust bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 520 shares of the company’s stock, valued at approximately $62,000.

Other institutional investors have also bought and sold shares of the company. Cyrus J. Lawrence LLC bought a new position in shares of Cardinal Health during the fourth quarter valued at $26,000. Promus Capital LLC acquired a new position in Cardinal Health in the fourth quarter worth $30,000. Lee Danner & Bass Inc. bought a new position in shares of Cardinal Health in the fourth quarter valued at about $35,000. Kentucky Trust Co acquired a new stake in Cardinal Health in the 4th quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC grew its stake in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after purchasing an additional 144 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent research reports. Mizuho started coverage on Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Argus set a $148.00 price target on shares of Cardinal Health in a research report on Tuesday, February 4th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a report on Tuesday, January 7th. Finally, Wells Fargo & Company upped their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Price Performance

Shares of CAH opened at $132.86 on Wednesday. The firm has a 50-day moving average of $127.78 and a 200-day moving average of $120.38. The company has a market cap of $32.09 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $133.68.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.52%. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.